Key Points
- The 2023 Annual Meeting of the American Association for Cancer Research was held April 14–19 in Orlando, Florida.
- Five focused ultrasound abstracts addressed melanoma, head and neck cancer, cancer cell models, and diffuse midline glioma.
The 2023 Annual Meeting of the American Association for Cancer Research (AACR) was held April 14–19 in Orlando, Florida.
Five focused ultrasound abstracts addressed melanoma, head and neck cancer, cancer cell models, and diffuse midline glioma. The full text of the abstracts is available on the AACR 2023 website.
Melanoma
1851/23 – Mechanisms underlying focused ultrasound-induced immunogenicity in melanoma by Sandra Pelka, Sanmay Bandyopadhyay, Sanjay Pandey, Chandan Guha, and Fernando Macian from the Albert Einstein College of Medicine (New York, NY)
2338/19 – Age associated tumor microenvironment induces differential outcomes from immunomodulatory nanoparticles and therapeutic ultrasound in murine melanoma by Akansha Singh, Jessica Fa De Oliveira, Steven Fiering, Josh Butcher, Nicole F. Steinmetz, and Ashish Ranjan from Oklahoma State University, University of California at San Diego, and Dartmouth Geisel School of Medicine (New Hampshire)
Head and Neck Cancer
2741/12 – Sexual dimorphism induces differential immunomodulatory outcomes from local nanoparticle and focused ultrasound therapy in murine model of head and neck cancer by Sri Vidhya Chandrasekar, Akansha Singh, and Ashish Ranjan from Oklahoma State University
Cancer Cell Models
2826/17 – Electromagnetic fields and hyperthermia induce lysosomal permeabilization and death in different cancer cell models: in vitro and in vivo studies by Elena Obrador, Ali Jihad-Jebbar, Rosario Salvador-Palmer, Rafael López-Blanch, María Oriol-Caballo, María Paz Moreno-Murciano, Enrique Navarro, Rosa Cibrián, and Jose M. Estrela from University of Valencia (Spain) and Scientia BioTech
Diffuse Midline Glioma
4304/2 – Network-based inference identifies cell state-specific drugs targeting master regulator vulnerabilities in diffuse midline glioma by Ester Calvo Fernandez, Junqiang Wang, Xu Zhang, Hong-Jian Wei, Hanna E. Minns, Aaron T. Griffin, Lukas Vlahos, Timothy J. Martins, Pamela S. Becker, John Crawford, Robyn D. Gartrell, Luca Szalontay, Stergios Zacharoulis, Zhiguo Zhang, Robert Wechsler-Reya, Cheng-Chia Wu, Andrea Califano, and Jovana Pavisic from Columbia University Irving Medical Center (New York, NY), University of Washington (Seattle, WA), University of California at Irvine, Children’s Hospital Orange County (Orange, CA), and Bristol Myers Squibb (New York, NY)
AACR describes its annual meeting as “the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.”